Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.

BACKGROUND: Surgery for colorectal liver metastases results in an overall survival of about 40% at 5 years. Progression-free survival is increased with the addition of oxaliplatin and fluorouracil chemotherapy. The addition of cetuximab to these chemotherapy regimens results in an overall survival a...

ver descrição completa

Detalhes bibliográficos
Autor principal: Bouchahda, M (author)
Outros Autores: Boige, V (author), Smith, D (author), Karaboué, A (author), Ducreux, M (author), Hebbar, M (author), Lepére, C (author), Focan, C (author), Guimbaud, R (author), Innominato, P (author), Awad, S (author), Carvalho, C (author), Tumolo, S, et al. (author)
Formato: article
Idioma:eng
Publicado em: 2016
Assuntos:
Colorectal neoplasms
Antineoplastic combined chemotherapy protocols
Neoplasm metastasis
Neoplasias colorrectais
Texto completo:http://hdl.handle.net/10400.10/1766
País:Portugal
Oai:oai:repositorio.hff.min-saude.pt:10400.10/1766

Texto Completo

http://hdl.handle.net/10400.10/1766

Registros relacionados